{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:49:36Z","timestamp":1791344976559,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s11010-005-5266-3","type":"journal-article","created":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T20:23:25Z","timestamp":1111004605000},"page":"107-113","source":"Crossref","is-referenced-by-count":9,"title":["The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL"],"prefix":"10.1007","volume":"270","author":[{"given":"Aleksandra A.","family":"Korotaeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Samoilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander I.","family":"Kaminny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejsandra A.","family":"Pirkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese J.","family":"Resink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Erne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina V.","family":"Prokazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vsevolod A.","family":"Tkachuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny I.","family":"Chazov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"13","volume-title":"The Restenosis Matrix","author":"De Scheerder","year":"2001","unstructured":"De Scheerder I. Restenosis: Multiple startegies for stent drug delivery. In: Rothman MT, (ed.). The Restenosis Matrix. ReMedica Publishing Limited, London, pp. 13?31, 2001"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","volume":"31","author":"R Kornowski","year":"1998","unstructured":"Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31: 224?230, 1998","journal-title":"J Am Coll Cardiol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00105-0","volume":"1488","author":"Six DA","year":"2000","unstructured":"Six DA, Dennis EA: The expanding superfamily of phospholipase A(2) enzymes: Classification and characterization. Biochim Biophys Acta 1488: 1?19, 2000","journal-title":"Biochim Biophys Acta"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1388-1981(00)00112-8","volume":"1488","author":"TJ Nevalainen","year":"2000","unstructured":"Nevalainen TJ, Haapam\u00e4ki MM, Gr\u00f6nroo JM: Roles of secretory phospholipase A2 in inflammatory diseases and trauma. Biochim Biophys Acta 1488: 83?90, 2000","journal-title":"Biochim Biophys Acta"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00003246-199602000-00013","volume":"24","author":"JM Gronroos","year":"1996","unstructured":"Gronroos JM, Kuttila K, Perttila J, Nevalainen TJ: Phospholipases A2 in the serum of patients after coronary artery bypass surgery. Crit Care Med 24: 259?262, 1996","journal-title":"Crit Care Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/jsre.1996.0003","volume":"60","author":"KM Nyman","year":"1996","unstructured":"Nyman KM, Uhl W, Forsstrom J, Buchler M, Beger HG, Nevalainen TJ: Serum phospholipase A2 in patients with multiple organ failure.J Surg Res 60: 7?14, 1996","journal-title":"J Surg Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.ATV.19.5.1284","volume":"19","author":"B Ivandic","year":"1999","unstructured":"Ivandic B, Castellani LW, Wang JU, Qiao JH, Mehrabian M, Navab M, Fogelman AM, Grass DS, Swanson ME, de Beer MC, de Bee F, Lusis AJ: Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. Arterioscler Thromb Vasc Biol 19: 1284?1290, 1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.ATV.17.10.2257","volume":"17","author":"LS Elinder","year":"1997","unstructured":"Elinder LS, Dumitrescu A, Larsson P, Hedin U, Frostegard J, Claesson HE: Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall. Arterioscler Thromb Vasc Biol 17: 2257?2263, 1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/01.ATV.17.2.300","volume":"17","author":"E Hurt-Camejo","year":"1997","unstructured":"Hurt-Camejo E, Andersen S, Standal R, Rosengren B, Sartipy P, Stadberg E, Johansen B: Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler Thromb Vasc Biol 17: 300?309, 1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0008-6363(03)00324-9","volume":"60","author":"H Niessen","year":"2003","unstructured":"Niessen H, Krijnen P, Visser C, Meijer C, Hack C: Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes? Cardiovasc Res 60: 68?77, 2003","journal-title":"Cardiovasc Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.CIR.100.12.1280","volume":"100","author":"K Kugiyama","year":"1999","unstructured":"Kugiyama K, Ota Y, Takazoe K, Moriyama Y, Kawano H, Miyao Y, Sakamoto T, Soejima H, Ogawa H, Doi H, Sugiyama S, Yasue H: Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease. Circulation 100: 1280?1284, 1999","journal-title":"Circulation"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"22895","DOI":"10.1074\/jbc.M002783200","volume":"275","author":"H Peilot","year":"2000","unstructured":"Peilot H, Rosengren B, Bondjers G, Hurt-Camejo E: Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT- 3 activation, and modulation by other cytokines. J Biol Chem 275: 22895?22904, 2000","journal-title":"J Biol Chem"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/344160a0","volume":"344","author":"K Kugiyama","year":"1990","unstructured":"Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344: 160?162, 1990","journal-title":"Nature"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI117047","volume":"93","author":"N Kume","year":"1994","unstructured":"Kume N, Gimbrone MA: Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93: 907?911, 1994","journal-title":"J Clin Invest"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.14.6.1007","volume":"14","author":"Y Ohara","year":"1994","unstructured":"Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG: Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb 14: 1007?1013, 1994","journal-title":"Arterioscler Thromb"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.RES.73.2.335","volume":"73","author":"K Kugiyama","year":"1993","unstructured":"Kugiyama K, Sakamoto T, Misumi I, Sugiyama S, Ohgushi M, Ogawa H, Horiguchi M, Yasue H: Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ Res 73: 335?343, 1993","journal-title":"Circ Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1096\/fasebj.6.11.1644257","volume":"6","author":"DP Hajjar","year":"1992","unstructured":"Hajjar DP, Pomerantz KB: Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. Faseb J 6: 2933?2941, 1992","journal-title":"Faseb J"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.98.4.353","volume":"98","author":"M Kohno","year":"1998","unstructured":"Kohno M, Yokokawa K, Yasunari K, Minami M, Kano H, Hanehira T, Yoshikawa J: Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Circulation 98: 353?359, 1998","journal-title":"Circulation"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/227810a0","volume":"227","author":"AR Poole","year":"1970","unstructured":"Poole AR, Howell JI, Lucy JA: Lysolecithin and cell fusion. Nature 227: 810?814, 1970","journal-title":"Nature"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-4157(79)90004-2","volume":"559","author":"HU Weltzien","year":"1979","unstructured":"Weltzien HU: Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta 559: 259?287, 1979","journal-title":"Biochim Biophys Acta"},{"key":"CR21","first-page":"521","volume":"10","author":"AA Korotaeva","year":"1997","unstructured":"Korotaeva AA, Cheglakov IB, Morozkin AD, Suslova IV, Prokazova NV: Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins. Membr Cell Biol 10: 521?534, 1997","journal-title":"Membr Cell Biol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/01.ATV.16.4.600","volume":"16","author":"M Sakai","year":"1996","unstructured":"Sakai M, Miyazaki A, Hakamata H, Sato Y, Matsumura T, Kobori S, Shichiri M, Horiuchi S: Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 16: 600?605, 1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/01.ATV.15.8.1131","volume":"15","author":"A Weidtmann","year":"1995","unstructured":"Weidtmann A, Scheithe R, Hrboticky N, Pietsch A, Lorenz R, Siess W: Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2. Arterioscler Thromb Vasc Biol 15: 1131?1138, 1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.ehj.2003.07.003","volume":"24","author":"Liu PY","year":"2003","unstructured":"Liu PY, Li YH, Tsai WC, Chao TH, Tsai LM, Wu HL, Chen JH: Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention. Eur Heart J 24: 1824?1832, 2003","journal-title":"Eur Heart J"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1053\/euhj.1999.1987","volume":"21","author":"M Gottsauner-Wolf","year":"2000","unstructured":"Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E, Wexberg P, Zorn G, Glogar D, Probst P, Maurer G, Huber K: Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 21: 1152?1158, 2000","journal-title":"Eur Heart J"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/01.CIR.92.1.31","volume":"92","author":"G Montalescot","year":"1995","unstructured":"Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thom D: Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 92: 31?38, 1995","journal-title":"Circulation"},{"key":"CR27","first-page":"793","volume":"294","author":"BS Cummings","year":"2000","unstructured":"Cummings BS, McHowat J, Schnellmann RG: Phospholipase A(2)s in cell injury and death. J Pharmacol Exp Ther 294: 793?799, 2000","journal-title":"J Pharmacol Exp Ther"},{"key":"CR28","first-page":"1","volume":"8","author":"P Vadas","year":"1993","unstructured":"Vadas P, Browning J, Edelson J, Pruzanski W: Extracellular phospholipase A2 expression and inflammation: The relationship with associated disease states. J Lipid Mediat 8: 1?30, 1993","journal-title":"J Lipid Mediat"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"21854","DOI":"10.1074\/jbc.M010201200","volume":"276","author":"S Akiba","year":"2001","unstructured":"Akiba S, Hatazawa R, Ono K, Kitatani K, Hayama M, Sato T: Secretory phospholipase A2 mediates cooperative prostaglandin generation by growth factor and cytokine independently of preceding cytosolic phospholipase A2 expression in rat gastric epithelial cells. J Biol Chem 276: 21854?21862, 2001","journal-title":"J Biol Chem"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"30527","DOI":"10.1074\/jbc.M008481200","volume":"276","author":"MW Anthonsen","year":"2001","unstructured":"Anthonsen MW, Solhaug A, Johansen B: Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor?alpha- and interleukin-1beta-induced NF- kappa B activation. J Biol Chem 276: 30527?30536, 2001","journal-title":"J Biol Chem"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1054\/tice.2000.0163","volume":"33","author":"M Schwemmer","year":"2001","unstructured":"Schwemmer M, Aho H, Michel JB: Interleukin-1beta-induced type IIA secreted phospholipase A2 gene expression and extracellular activity in rat vascular endothelial cells. Tissue Cell 33: 233?240, 2001","journal-title":"Tissue Cell"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/1521-4141(200201)32:1<67::AID-IMMU67>3.0.CO;2-3","volume":"32","author":"M Triggiani","year":"2002","unstructured":"Triggiani M, Granata F, Oriente A, Gentile M, Petraroli A, Balestrieri B, Marone G: Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes. Eur J Immunol 32: 67?76, 2002","journal-title":"Eur J Immunol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0005-2760(96)00169-5","volume":"1345","author":"Y Zhu","year":"1997","unstructured":"Zhu Y, Lin JH, Liao HL, Verna L, Stemerman MB: Activation of ICAM-1 promoter by lysophosphatidylcholine: Possible involvement of protein tyrosine kinases. Biochim Biophys Acta 1345: 93?98, 1997","journal-title":"Biochim Biophys Acta"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1006\/bbrc.1995.1388","volume":"208","author":"MD Rosenthal","year":"1995","unstructured":"Rosenthal MD, Gordon MN, Buescher ES, Slusser JH, Harris LK, Franson RC: Human neutrophils store type II 14-kDa phospholipase A2 in granules and secrete active enzyme in response to soluble stimuli. Biochem Biophys Res Commun 208: 650?656, 1995","journal-title":"Biochem Biophys Res Commun"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0929-7855(94)00037-D","volume":"11","author":"P Vadas","year":"1995","unstructured":"Vadas P, Stefanski E, Grouix B, Schouten BD, Pruzanski W: Inhibition of human group II phospholipase A2 by C-reactive protein in vitro. J Lipid Mediat Cell Signal 11: 187?200, 1995","journal-title":"J Lipid Mediat Cell Signal"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1248\/bpb.23.1163","volume":"23","author":"TC Moon","year":"2000","unstructured":"Moon TC, Lee JH, Lee SH, Park YK, Baek SH, Chan HW: Detection and characterization of a type IIA secretory phospholipase A2 inhibitory protein in human amniotic fluid. Biol Pharm Bull 23: 1163?1166, 2000","journal-title":"Biol Pharm Bull"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1388-1981(00)00110-4","volume":"1488","author":"E Valentin","year":"2000","unstructured":"Valentin E, Lambeau G:, Increasing molecular diversity of secreted phospholipase A2 and their receptors and binding proteins. Biochim Biophys Acta 1488: 59?70, 2000","journal-title":"Biochim Biophys Acta"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1172\/JCI3236","volume":"102","author":"L Arbibe","year":"1998","unstructured":"Arbibe L, Koumanov K, Vial D, Rougeot C, Faure G, Havet N, Longacre S, Vargafting BB, Bereziat G, Voelker DR, Wolf C, Touqui L:, Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest 102: 1152?1160, 1998","journal-title":"J Clin Invest"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/01.RES.71.6.1422","volume":"71","author":"K Kugiyama","year":"1992","unstructured":"Kugiyama K, Ohgushi M, Sugiyama S, Murohara T, Fukunaga K, Miyamoto E, Yasue H. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res 71: 1422?1428, 1992","journal-title":"Circ Res"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5551\/jat1994.2.81","volume":"2","author":"M Sakai","year":"1996","unstructured":"Sakai M, Miyazaki A, Hakamata H, Kobori S, Shichiri M, Horiuchi S: Endocytic uptake of lysophosphatidylcholine mediated by macrophage scavenger receptor plays a major role in oxidized low density lipoprotein-induced macrophage growth. J Atheroscler Thromb 2: 81?86, 1996","journal-title":"J Atheroscler Thromb"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0022-2275(20)42839-1","volume":"31","author":"M Kinoshita","year":"1990","unstructured":"Kinoshita M, Krul ES, Schonfeld G: Modification of the core lipids of low density lipoproteins produces selective alterations in the expression of apoB-100 epitopes. J Lipid Res 31: 701?708, 1990","journal-title":"J Lipid Res"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0022-2275(20)38488-1","volume":"29","author":"Y Kleinman","year":"1988","unstructured":"Kleinman Y, Krul ES, Burnes M, Aronson W, Pfleger B, Schonfeld G: Lipolysis of LDL with phospholipase A2 alters the expression of selected apoB-100 epitopes and the interaction of LDL with cells. J Lipid Res 29: 729?743, 1988","journal-title":"J Lipid Res"},{"key":"CR43","first-page":"1430","volume":"63","author":"AA Korotaeva","year":"1998","unstructured":"Korotaeva AA, Golovanova NK, Vlasik TN, Yanushevskaya EV, Tsibulsky VP, Yakushkin VV, Tvorogova MG, Morozkin AD, Prokazova NV: Immunoreactivity of apolipoprotein B-100 and binding to LDL-receptor of phospholipase A2-treated low density lipoproteins. Biochemistry (Mosc) 63: 1430?1437, 1998","journal-title":"Biochemistry (Mosc)"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00041433-200010000-00004","volume":"11","author":"E Hurt-Camejo","year":"2000","unstructured":"Hurt-Camejo E, Camejo G, Sartipy P: Phospholipase A2 and small, dense low-density lipoprotein. Curr Opin Lipidol 11: 465?471, 2000","journal-title":"Curr Opin Lipidol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-005-5266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-005-5266-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-005-5266-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:15:35Z","timestamp":1625616935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-005-5266-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["5266"],"URL":"https:\/\/doi.org\/10.1007\/s11010-005-5266-3","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}